ME26 virus, which was generated by inserting the coding region of the acute avian leukemia-inducing virus E26 into a murine retrovirus vector, encodes a 135-kDa gag-myb-ets fusion protein. 
ME26 virus, which was generated by inserting the coding region of the acute avian leukemia-inducing virus E26 into a murine retrovirus vector, encodes a 135-kDa gag-myb-ets fusion protein. Amphotropic murine leukemia virus pseudotypes of ME26 virus induce a high incidence of erythroleukemia 2 to 4 months after injection into newborn NFS/N mice. Spleen cells from the majority of these mice proliferate to high levels in the presence of the erythroid hormone erythropoietin (Epo) and can easily be established as permanent Epo-dependent cell lines. The cell lines contain multiple copies of ME26 viral DNA and express viral message and protein. An Epo receptor mRNA of normal size can be detected in these cells, and binding studies reveal a single class of lower-affinity Epo receptor with an affinity for Epo that is in the range of that previously reported for erythroid cells. The ME26 virus-induced Epo-dependent cell lines, however, appear more immature than previously described erythroid cell lines and more closely resemble early hematopoietic precursor cells, suggesting that the virus may be activating the Epo receptor in hematopoietic cells that do not normally express it. Consistent with this idea, we are able to infect an interleukin-3-dependent myeloid cell line, FDC-P2, with ME26 virus and convert it to Epo dependence. The ME26 virus-infected FDC-P2 cells, even before growth on Epo, showed a large increase in the amount of Epo receptor mRNA. However, no ME26 viral integrations can be detected adjacent to the Epo receptor gene, indicating that the virus is not activating the Epo receptor gene by promoter/enhancer insertion. Our results are more consistent with the hypothesis that the gag-myb-ets-encoded viral fusion protein, which is known to bind DNA, is directly or indirectly activating the expression of the Epo receptor gene in these cells.
E26 virus is a defective avian retrovirus which predominantly induces erythroblastosis in infected chickens (16) . In vitro, the virus can transform avian cells of both erythroid and myeloid lineages, suggesting that it may transform uncommitted erythroid/myeloid precursor cells (17, 19) . Molecular analysis of the E26 virus has shown that it has transduced two proto-oncogenes, myb and ets (11, 18) , which are expressed as a 135-kDa Gag-Myb-Ets fusion protein (2) . Since myb sequences have previously been associated with myeloid leukemia, it is thought that the v-ets sequences are responsible for the erythroid-transforming potential of the virus in conjunction with the v-myb sequences.
To study the effects of the fused myb and ets sequences on mouse cells, a murine equivalent of the avian E26 virus, designated ME26 virus, was constructed by inserting the gag-myb-ets coding region of the E26 virus into a murine retrovirus vector derived from Abelson murine leukemia virus (MuLV) (30 (25) . Two days later, individual clots were harvested and stained with benzidinehematoxylin. Benzidine-positive late erythroid CFU (CFU-E)-derived colonies were counted under the microscope.
Epo binding assays. Epo was iodinated, and 125I-Epo binding assays were carried out as previously described (24) . Cells were washed and cultured in the absence of Epo overnight to increase the receptor number and reduce the occupancy of receptors. Cells (107) were then incubated for 20 h at 0°C in concentrations of 125I-Epo ranging from 0.1 to 10 U/ml (26 to 2,600 pM). Bound Epo was measured by separation of the cells from the binding medium by centrifugation through dibutyl phthalate oil. Nonspecific binding was measured in the presence of 100 U of unlabeled Epo per ml and was subtracted from specific binding. The data were plotted by the Scatchard method to determine the binding affinity.
Northern (RNA) and Southern (DNA) blot hybridization analysis. Total RNA was purified by using RNAzol (4) .
RNAs were denatured in 50% formamide-2.2 M formaldehyde, separated electrophoretically on 1.2% agarose gels containing 2.2 M formaldehyde, and transferred to nitrocellulose filters. RNA containing Epo receptor sequences was identified by hybridization with a random-primed probe prepared from a 1.9-kb fragment of the Epo receptor cDNA from plasmid pXM(ER) (5) (kindly provided by A. D'Andrea, Dana Farber Cancer Institute, Boston, Mass.). Hybridizations were also carried out by using a v-ets probe (E1.28) (27) to detect expression of the ME26 virus. Hybridizations were performed at 42°C for 24 h in 50% formamide-5x SSC (lx SSC is 0.15 M NaCl plus 0.015 M sodium citrate) and were followed by two washes at room temperature with 2x SSC-0.1% sodium dodecyl sulfate (SDS) and two washes at 42°C with 0.2x SSC-0.1% SDS. DNA was prepared as previously described (3). Highmolecular-weight DNA was digested with restriction enzymes, electrophoresed in 1% agarose gels, and transferred to nitrocellulose filters. Filters were hybridized to either a 32P-labeled probe to v-ets or to a probe prepared to a HindIII-XbaI fragment derived from the promoter region of the Epo receptor gene (pO.45GH) (29) (kindly provided by H. Youssoufian, Whitehead Institute for Biomedical Research, Cambridge, Mass.). Hybridizations were performed for 24 h in 50% formamide-5 x SSC and were followed by washing as described above for analysis of RNA.
RESULTS
Effects of ME26 virus on mouse erythroid cells. In an effort to better understand the effects of the ME26 virus on the Epo pathway, we analyzed spleen cells from leukemic NFS/N mice infected 2 to 3 months previously with AMT/ME26. Only mice that were anemic (hematocrit below 35%) and showed no lymph node involvement were chosen for this study. Since normal erythroid cells are dependent on the erythroid hormone Epo for proliferation and differentiation, we measured the effect of this hormone on the growth and differentiation of spleen cells from ME26 virus-infected mice. As shown in Fig. 1 , spleen cells from mice infected with AMT/ME26, like those of erythroleukemic mice infected with AMT/SFFVA, proliferated to high levels only in the presence of the erythroid hormone Epo. In contrast, spleens from mice infected with amphotropic helper virus alone (AMT) contain only a low number of Epo-responsive cells, like spleens from uninfected mice.
Spleen cells from virus-infected mice were also analyzed in semisolid medium for their ability to form CFU-E in the presence or absence of Epo. As shown in Table 1 , spleens from mice infected with AMT/ME26 virus showed no increase in Epo-dependent CFU-E over that seen with spleens from mice infected with AMT-MuLV alone, indicating that the Epo-responsive cells proliferating to high levels in the AMT/ME26 virus-infected mice are blocked from differentiating into mature erythrocytes. This contrasts with spleens from mice infected with AMT/SFFVA, which show a large increase in the number of Epo-dependent CFU-E.
Development and characterization of Epo-dependent cell lines from ME26 virus-infected mice. When spleen cells from ME26 virus-infected mice were put into culture in medium with or without recombinant human Epo, Epo-dependent cell lines could easily and reproducibly be obtained from these mice. Of 64 spleens cultured, 45 (70%) were successfully established as permanent cell lines. The lines were established within a few days of culturing and appeared to represent the major population of cells growing in the spleens of the infected mice rather than a rare cell selected out of the spleen cell population. In contrast, no lines could be established from the spleens of normal mice or mice infected with amphotropic helper virus alone. All but two of the lines required the continued presence of Epo for proliferation and each line failed to proliferate in response to any other growth factor tested (IL-1 through IL-7, granulocyte colony-stimulating factor, granulocyte-macrophage colonystimulating factor, and colony-stimulating factor 1). All but (Fig. 2) . Southern analysis using a v-ets probe showed similar hybridization patterns in DNA from the established cell lines and in the spleen cells from which they were derived, consistent with the idea that the cell lines are representative of the majority of the cells proliferating in the diseased spleens of the infected mice. The cell lines also express viral RNA and the 135-kDa protein product of the ME26 virus, and they produce virus that was active on fibroblasts in vitro (30) and was able to induce leukemia in mice (data not shown).
The Epo receptors on the ME26 virus-induced Epodependent cell lines were also analyzed and compared with the receptors on HCD-57 cells, an Epo-dependent erythroleukemia cell line induced by Fr-MuLV. All of the ME26 virus-induced cell lines examined express an Epo receptor mRNA (Fig. 3, lanes 1 to 5) hemin (data not shown). They fail to express any cell surface markers specific for myeloid or lymphoid lineages or markers often, but not always, detected on hematopoietic stem cells (i.e., Thy-1 and Ly-6) (15a).
5-Fluorouracil treatment increases the target cells for ME26 virus. Unlike newborn mice, adult mice are not susceptible to ME26 virus-induced leukemia (30) , suggesting that there may be fewer target cells for the virus in the adult mouse. In an effort to increase the target cells for ME26 virus, adult NFS/N mice were treated prior to virus infection with either phenylhydrazine, which leads to a large increase in late erythroid precursor cells (10), or 5-fluorouracil, which greatly increases the number of uncommitted hematopoietic progenitor cells (26) . Sixty percent (9 of 15) of adult mice pretreated with 5-fluorouracil before being given ME26 virus developed leukemia within 150 days postinfection. Untreated adult mice or mice pretreated with phenylhydrazine failed to develop disease following infection with ME26 virus. The disease induced by ME26 virus in the 5-fluorouracil-treated mice was indistinguishable from that induced in newborns by the virus, and the cells from these diseased mice also grew as permanent Epo-dependent cell lines. This result, combined with the morphological characteristics of the cells transformed by the virus, suggest that ME26 virus may not be transforming a committed erythroid precursor cell but may be inducing Epo responsiveness in a less mature hematopoietic cell that does not normally express the Epo receptor.
Effects of ME26 virus on an IL-3-dependent myeloid cell line. To test the possibility that ME26 virus was inducing Epo responsiveness in an hematopoietic cell that did not normally express the Epo receptor, an IL-3-dependent myeloid cell line, FDC-P2, was infected with ME26 virus. As shown in Table 3 , FDC-P2 cells infected with AMT/ME26 or Fr/ME26 were. able to grow in medium containing only Epo. Uninfected cells or cells infected with AMT-MuLV or FrMuLV helper virus alone grew only in the presence of IL-3, indicating that ME26 virus was responsible for inducing Epo responsiveness. ME26 virus-infected FDC-P2 cells failed to grow in the absence of either IL-3 or Epo, indicating that the virus had not rendered them factor independent. Furthermore, growth factors other than IL-3 or Epo were not able to sustain the growth of these cells, indicating that the virus was specifically inducing Epo responsiveness.
ME26 virus-infected FDC-P2 cells plated in soft agar in the presence of either Epo or IL-3 formed compact colonies (Table 3 ). In contrast, uninfected FDC-P2 cells or cells infected with helper virus alone formed diffuse colonies in the presence of IL-3 and no colonies in the presence of Epo. The cloning efficiency of ME26 virus-infected cells, when grown with either IL-3 or Epo, was significantly higher than that of the uninfected or helper virus-infected cells, suggesting that ME26 virus infection confers a growth advantage on these cells.
The ME26 virus-infected FDC-P2 cells express large amounts of ME26 viral mRNA (Fig. 5) as well as the ME26 virus-encoded protein (data not shown). Furthermore, the cells show a greatly enhanced level of Epo receptor mRNA compared with their uninfected counterparts (Fig. 5) , indicating that ME26 virus is activating expression of the Epo receptor in these cells. ME26 virus infection appears to induce Epo responsiveness in FDC-P2 cells rather than select for a rare Epo-responsive cell in the population, since high levels of Epo receptor mRNA could be detected in the ME26 virus-infected cells even before the cells were grown on Epo.
Analysis of the Epo receptor gene in ME26 virus-infected, Epo-responsive hematopoietic cell lines. To determine whether ME26 virus was inducing the expression of the Epo receptor gene by promoter/enhancer insertion, a probe specific for the promoter region of the Epo receptor gene was used to analyze DNA from ME26 virus-induced Epo-dependent cell lines and ME26 virus-infected FDC-P2 cells for any rearrangements compared with the Epo receptor gene in normal NFSIN mouse tissues. DNAs were cut with AvaI, which cleaves at the 5' end of the first exon within the Epo receptor gene, and Southern analysis was performed using a probe specific for the Epo receptor promoter region. As shown in Fig. 6, (1) suggest that ME26 virus alone does not significantly activate the Epo receptor promoter after cotransfection into fibroblasts but may be transactivating the GATA-I gene, which encodes an erythroid-specific transcription factor which can transactivate a number of genes (7, 8, 12, 13, 28) , including the Epo receptor gene (31) .
The role of particular ME26 viral sequences in the induction of Epo responsiveness is under investigation. Recent studies with derivatives of the avian E26 virus have indicated that only those viruses expressing myb and ets sequences on a single fusion protein are leukemogenic (14) . Studies in progress in our laboratory using mutants of ME26 virus that contain changes in either the myb or ets domain suggest that the intact virus may be needed for the induction ...*.,.aA not the only step involved in the generation of an immortal population of Epo-dependent cells. The cell lines described in this study were generated from the spleens of mice sacrificed 60 to 90 days after virus infection. Attempts to develop Epo-dependent cell lines from mice sacrificed between 30 and 60 days, even though their spleens contained a large population of Epo-responsive cells, were less successful. This finding suggests that additional changes are required to generate Epo-dependent cells capable of continuous growth in culture. As has been observed in other virus-induced hematopoietic neoplasms, it is possible that promoter/enhancer insertion, involving either the defective ME26 virus or its amphotropic MuLV helper, is responsible for their immortalization. These changes may also involve a differentiation block, because the immortal cell lines are unable to differentiate, while cells replicating in the animal early in the course of disease were able to differentiate into mature erythrocytes. Since the production of Epo is regulated by the level of mature erythrocytes being produced, the growth of the Epo-dependent, ME26 virus-infected cells would be favored by a block in differentiation, leading to high levels of Epo in response to the depletion of mature erythroid cells. Studies are currently under way to determine the role of the virus in immortalizing the Epo-dependent cells.
It is interesting that of the three viruses known to cause erythroleukemia in mice, two of them, Fr-SFFV and FrMuLV, are associated with the activation of ets-related genes Spi-J (9, 15) and Fli-i (la), respectively, and the third, ME26 virus, expresses an ets-related protein. This suggests that abnormal expression of ets-related genes in erythroid precursor cells, either by insertional activation or by retroviral transduction of the gene, may lead to a malignant state. Further studies with the ME26 virus should provide insights into the role of one member of the ets gene family in the regulation of hematopoietic cell growth. 
